Pediatric acute-onset neuropsychiatric syndrome

Psychiatric Clinics of North America

Volumn 37, Issue 3, 2014, Pages 353-374

  Murphy, Tanya K ^a   Gerardi, Diana M ^a   Leckman, James F ^b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

PANDAS; Pediatric autoimmune neuropsychiatric disorder; Streptococcal infections

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ARIPIPRAZOLE; AZITHROMYCIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CEFDINIR; CELECOXIB; CEPHALOSPORIN; CORTICOTROPIN; FLUOXETINE; GUANFACINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PENICILLIN DERIVATIVE; PLACEBO; PREDNISONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; ANTIINFECTIVE AGENT;

ALLERGIC REACTION; ANOREXIA; ATTENTION DEFICIT DISORDER; BORRELIA INFECTION; CHOREA MINOR; COGNITIVE DEFECT; COGNITIVE THERAPY; DRUG SAFETY; DRUG TOLERABILITY; GASTROINTESTINAL SYMPTOM; GROUP A STREPTOCOCCAL INFECTION; HALLUCINATION; HUMAN; INFLUENZA; LOW DRUG DOSE; LYME DISEASE; MENTAL DISEASE; MOOD DISORDER; MYCOPLASMA PNEUMONIA; MYCOPLASMOSIS; NONHUMAN; OBSESSIVE COMPULSIVE DISORDER; PEDIATRIC ACUTE ONSET NEUROPSYCHIATRIC SYNDROME; PEDIATRIC AUTOIMMUNE NEUROPSYCHIATRIC DISORDER; PLASMAPHERESIS; POLLAKISURIA; PRIORITY JOURNAL; PSYCHOSIS; QT PROLONGATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SEPARATION ANXIETY; SYMPTOMATOLOGY; TIC; TONSILLECTOMY; AUTOIMMUNE DISEASES; MULTIMODALITY CANCER THERAPY; OBSESSIVE-COMPULSIVE DISORDER; PATHOPHYSIOLOGY; STREPTOCOCCAL INFECTIONS;

ANTI-BACTERIAL AGENTS; AUTOIMMUNE DISEASES; COMBINED MODALITY THERAPY; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; OBSESSIVE-COMPULSIVE DISORDER; PLASMA EXCHANGE; RISK FACTORS; STREPTOCOCCAL INFECTIONS; TONSILLECTOMY;

EID: 84906236192     PISSN: 0193953X     EISSN: 15583147     Source Type: Journal    
DOI: 10.1016/j.psc.2014.06.001     Document Type: Review

References (153)

1. Swedo S.E., Leonard H.L., Garvey M., et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry 1998, 155(2):264-271.
2. Swedo S., Leckman J., Rose N. From research subgroup to clinical syndrome: modifying the PANDAS criteria to describe PANS. Pediatric Therapeutics 2012, 2(113).
3. Geller D.A., March J. Practice parameter for the assessment and treatment of children and adolescents with obsessive-compulsive disorder. Focus 2012, 10(3):360-373.
4. Wise S.P., Rapoport J.L. Obsessive-compulsive disorder: is it basal ganglia dysfunction. Obsessive-compulsive disorder in children and adolescents 1989, 327-344. American Psychiatric Press, Washington, DC. J.L. Rapoport (Ed.).
5. Rosenberg D.R., Averbach D.H., O'Hearn K.M., et al. Oculomotor response inhibition abnormalities in pediatric obsessive-compulsive disorder. Arch Gen Psychiatry 1997, 54(9):831.
6. Bannon S., Gonsalvez C.J., Croft R.J., et al. Executive functions in obsessive-compulsive disorder: state or trait deficits?. Aust N Z J Psychiatry 2006, 40(11-12):1031-1038.
7. Chang S.W., McCracken J.T., Piacentini J.C. Neurocognitive correlates of child obsessive compulsive disorder and Tourette syndrome. JClin Exp Neuropsychol 2007, 29(7):724-733.
8. Zandt F., Prior M., Kyrios M. Similarities and differences between children and adolescents with autism spectrum disorder and those with obsessive compulsive disorder: executive functioning and repetitive behaviour. Autism 2009, 13(1):43-57.
9. Ornstein T.J., Arnold P., Manassis K., et al. Neuropsychological performance in childhood OCD: a preliminary study. Depress Anxiety 2010, 27(4):372-380.
10. Hirschtritt M.E., Hammond C.J., Luckenbaugh D., et al. Executive and attention functioning among children in the PANDAS subgroup. Child Neuropsychol 2009, 15(2):179-194.
11. Lewin A.B., Storch E.A., Mutch P.J., et al. Neurocognitive functioning in youth with pediatric autoimmune neuropsychiatric disorders associated with streptococcus. JNeuropsychiatry Clin Neurosci 2011, 23(4):391-398.
12. Murphy T.K., Storch E.A., Lewin A.B., et al. Clinical factors associated with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. JPediatr 2012, 160(2):314-319.
13. Rosenberg D.R., Keshavan M.S., O'Hearn K.M., et al. Frontostriatal measurement in treatment-naive children with obsessive-compulsive disorder. Arch Gen Psychiatry 1997, 54(9):824.
14. Giedd J.N., Rapoport J.L., Garvey M.A., et al. MRI assessment of children with obsessive-compulsive disorder or tics associated with streptococcal infection. Am J Psychiatry 2000, 157(2):281-283.
15. Giedd J.N., Rapoport J.L., Leonard H.L., et al. Case study: acute basal ganglia enlargement and obsessive-compulsive symptoms in an adolescent boy. JAm Acad Child Adolesc Psychiatry 1996, 35(7):913-915.
16. Kumar A, Williams MT, Chugani HT. Evaluation of basal ganglia and thalamic inflammation in children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection and Tourette syndrome: a positron emission tomographic (PET) study using C-[R]-PK11195. J Child Neurol, in press.
17. Nicolson R., Swedo S.E., Lenane M., et al. An open trial of plasma exchange in childhood-onset obsessive-compulsive disorder without poststreptococcal exacerbations. JAm Acad Child Adolesc Psychiatry 2000, 39(10):1313-1315.
18. Perlmutter S.J., Leitman S.F., Garvey M.A., et al. Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood. Lancet 1999, 354(9185):1153-1158.
19. Garvey M.A., Perlmutter S.J., Allen A.J., et al. Apilot study of penicillin prophylaxis for neuropsychiatric exacerbations triggered by streptococcal infections. Biol Psychiatry 1999, 45(12):1564-1571.
20. Murphy M.L., Pichichero M.E. Prospective identification and treatment of children with pediatric autoimmune neuropsychiatric disorder associated with group A streptococcal infection (PANDAS). Arch Pediatr Adolesc Med 2002, 156(4):356.
21. Snider L.A., Lougee L., Slattery M., et al. Antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuropsychiatric disorders. Biol Psychiatry 2005, 57(7):788-792.
22. Storch E.A., Björgvinsson T., Riemann B., et al. Factors associated with poor response in cognitive-behavioral therapy for pediatric obsessive-compulsive disorder. Bull Menninger Clin 2010, 74(2):167-185.
23. Storch E.A., Geffken G.R., Merlo L.J., et al. Family-based cognitive-behavioral therapy for pediatric obsessive-compulsive disorder: comparison of intensive and weekly approaches. JAm Acad Child Adolesc Psychiatry 2007, 46(4):469-478.
24. March J.S., Foa E., Gammon P., et al. Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder-The Pediatric OCD Treatment Study (POTS) randomized controlled trial. JAMA 2004, 292(16):1969-1976.
25. Storch E.A., Gerdes A.C., Adkins J.W., et al. Behavioral treatment of a child with PANDAS. JAm Acad Child Adolesc Psychiatry 2004, 43(5):510-511.
26. Storch E.A., Murphy T.K., Geffken G.R., et al. Cognitive-behavioral therapy for PANDAS-related obsessive-compulsive disorder: findings from a preliminary waitlist controlled open trial. JAm Acad Child Adolesc Psychiatry 2006, 45(10):1171-1178.
27. Geller D.A., Wagner K.D., Emslie G., et al. Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: a randomized, multicenter, double-blind, placebo-controlled trial. JAm Acad Child Adolesc Psychiatry 2004, 43(11):1387-1396.
28. Murphy T.K., Storch E.A., Strawser M.S. Selective serotonin reuptake inhibitor-induced behavioral activation in the PANDAS subtype. Prim Psychiatr 2006, 13(8):87-89.
29. Langley A.K., Lewin A.B., Bergman R.L., et al. Correlates of comorbid anxiety and externalizing disorders in childhood obsessive compulsive disorder. Eur Child Adolesc Psychiatry 2010, 19(8):637-645.
30. Coskun M., Zoroglu S., Ozturk M. Phenomenology, psychiatric comorbidity and family history in referred preschool children with obsessive-compulsive disorder. Child Adolesc Psychiatry Ment Health 2012, 6(1):36.
31. Bernstein G.A., Victor A.M., Pipal A.J., et al. Comparison of clinical characteristics of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and childhood obsessive-compulsive disorder. JChild Adolesc Psychopharmacol 2010, 20(4):333-340.
32. Murphy T.K., Kurlan R., Leckman J. The immunobiology of Tourette's disorder, pediatric autoimmune neuropsychiatric disorders associated with Streptococcus, and related disorders: a way forward. JChild Adolesc Psychopharmacol 2010, 20(4):317-331.
33. Lougee L., Perlmutter S.J., Nicolson R., et al. Psychiatric disorders in first-degree relatives of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS). JAm Acad Child Adolesc Psychiatry 2000, 39(9):1120-1126.
34. Murphy T.K., Snider L.A., Mutch P.J., et al. Relationship of movements and behaviors to Group A streptococcus infections in elementary school children. Biol Psychiatry 2007, 61(3):279-284.
35. Sydenham T., Latham R.G. The works of Thomas Sydenham, MD 1850, vol. 2. Printed for the Sydenham Society, London.
36. Osler W. On Chorea and Choreiform Affections 1894, 33-35. H.K. Lewis, London(UK).
37. Grimshaw L. Obsessional disorder and neurological illness. J Neurol Neurosurg Psychiatry 1964, 27:229-231.
38. Keeler W., Bender L. Afollow-up study of children with behavior disorder and Sydenham's chorea. Am J Psychiatry 1952, 109(6):421-428.
39. Swedo S.E., Rapoport J.L., Cheslow D., et al. High prevalence of obsessive-compulsive symptoms in patients with Sydenham's chorea. Am J Psychiatry 1989, 146(2):246-249.
40. Swedo S.E., Leonard H.L., Casey B., et al. Sydenham's chorea: physical and psychological symptoms of St Vitus dance. Pediatrics 1993, 91(4):706-713.
41. Abbas S., Khanna S., Taly A. Obsessive-compulsive disorder and rheumatic chorea: is there a connection?. Psychopathology 1996, 29(3):193-197.
42. Asbahr F.R., Negrão A.B., Gentil V., et al. Obsessive-compulsive and related symptoms in children and adolescents with rheumatic fever with and without chorea: a prospective 6-month study. Am J Psychiatry 1998, 155(8):1122-1124.
43. Moore D.P. Neuropsychiatric aspects of Sydenham's chorea: a comprehensive review. JClin Psychiatry 1996, 57(9):407-414.
44. Swedo S.E. Sydenham's chorea: a model for childhood autoimmune neuropsychiatric disorders. JAMA 1994, 272(22):1788-1791.
45. Selling L. The role of infection in the etiology of tics. Arch Neurol Psychiatr 1929, 22(6):1163.
46. Langlois M., Force L. Nosologic and clinical revision of Gilles de la Tourette disease evoked by the action of certain neuroleptics on its course. Rev Neurol 1965, 113(6):641.
47. Boris M. Gilles de la Tourette's syndrome: remission with haloperidol. JAMA 1968, 205(9):648-649.
48. Shapiro A.K., Shapiro E. Treatment of Gilles de la Tourette's syndrome with haloperidol. Br J Psychiatry 1968, 114(508):345-350.
49. Goldstone S., Lhamon W.T. The effects of haloperidol upon temporal information processing by patients with Tourette's syndrome. Psychopharmacology 1976, 50(1):7-10.
50. Messiha F.S., Knopp W., Vanecko S., et al. Haloperidol therapy in Tourette's syndrome: neurophysiological, biochemical and behavioral correlates. Life Sci 1971, 10(8):449-457.
51. Shapiro A.K., Shapiro E., Wayne H. Treatment of Tourette's syndrome: with haloperidol, review of 34 cases. Arch Gen Psychiatry 1973, 28(1):92.
52. Matarazzo E.B. Tourette's syndrome treated with ACTH and prednisone: report of two cases. JChild Adolesc Psychopharmacol 1992, 2(3):215-226.
53. Mell L.K., Davis R.L., Owens D. Association between streptococcal infection and obsessive-compulsive disorder, Tourette's syndrome, and tic disorder. Pediatrics 2005, 116(1):56-60.
54. de Oliveira S.K., Pelajo C.F. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS): a controversial diagnosis. Curr Infect Dis Rep 2010, 12(2):103-109.
55. Gabbay V., Coffey B. Obsessive-compulsive disorder, Tourette's disorder, or pediatric autoimmune neuropsychiatric disorders associated with Streptococcus in an adolescent? Diagnostic and therapeutic challenges. JChild Adolesc Psychopharmacol 2003, 13(3):209-212.
56. Gabbay V., Coffey B.J., Babb J.S., et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcus: comparison of diagnosis and treatment in the community and at a specialty clinic. Pediatrics 2008, 122(2):273-278.
57. Giulino L., Gammon P., Sullivan K., et al. Is parental report of upper respiratory infection at the onset of obsessive-compulsive disorder suggestive of pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection?. JChild Adolesc Psychopharmacol 2002, 12(2):157-164.
58. Kurlan R., Kaplan E.L. The pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) etiology for tics and obsessive-compulsive symptoms: hypothesis or entity? Practical considerations for the clinician. Pediatrics 2004, 113(4):883-886.
59. Kurlan R., Johnson D., Kaplan E.L. Streptococcal infection and exacerbations of childhood tics and obsessive-compulsive symptoms: a prospective blinded cohort study. Pediatrics 2008, 121(6):1188-1197.
60. Larson M., Storch E., Murphy T. What are the diagnostic and treatment implications for PANDAS: pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. Curr Psychiatr 2005, 4:33-48.
61. Macerollo A., Martino D. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS): an evolving concept. Tremor Other Hyperkinet Mov (N Y) 2013, 3. pii:tre-03-167-4158-7.
62. Murphy T.K., Petitto J.M., Voeller K.K.S., et al. Obsessive Compulsive Disorder: Is there an Association with Childhood Streptococcal Infections and Altered Immune Function?. Seminars in Clinical Neuropsychiatry October 2001, 6(4):266-276.
63. Perrin E.M., Murphy M.L., Casey J.R., et al. Does group A beta-hemolytic streptococcal infection increase risk for behavioral and neuropsychiatric symptoms in children?. Arch Pediatr Adolesc Med 2004, 158(9):848-856.
64. Singer H.S., Loiselle C.R., Lee O., et al. Anti-basal ganglia antibodies in PANDAS. Mov Disord 2004, 19(4):406-415.
65. Snider L.A., Swedo S.E. PANDAS: current status and directions for research. Mol Psychiatry 2004, 9(10):900-907.
66. Murphy T.K., Sajid M., Soto O., et al. Detecting pediatric autoimmune neuropsychiatric disorders associated with streptococcus in children with obsessive-compulsive disorder and tics. Biol Psychiatry 2004, 55(1):61-68.
67. Leslie D.L., Kozma L., Martin A., et al. Neuropsychiatric disorders associated withstreptococcal infection: a case-control study among privately insured children. J Am Acad Child Adolesc Psychiatry 2008, 47:1166-1172.
68. Leckman J.F., King R.A., Gilbert D.L., et al. Streptococcal upper respiratory tract infections and exacerbations of tic and obsessive-compulsive symptoms: a prospective longitudinal study. JAm Acad Child Adolesc Psychiatry 2011, 50(2):108-118.e3.
69. Schrag A., Gilbert R., Giovannoni G., et al. Streptococcal infection, Tourette syndrome, and OCD. Is there a connection?. Neurology 2009, 73(16):1256-1263.
70. Luo F., Leckman J.F., Katsovich L., et al. Prospective longitudinal study of children with tic disorders and/or obsessive-compulsive disorder: relationship of symptom exacerbations to newly acquired streptococcal infections. Pediatrics 2004, 113(6):e578-e585.
71. Kiessling L.S., Marcotte A.C., Culpepper L. Antineuronal antibodies in movement disorders. Pediatrics 1993, 92(1):39-43.
72. Morris C.M., Pardo-Villamizar C., Gause C.D., et al. Serum autoantibodies measured by immunofluorescence confirm a failure to differentiate PANDAS and Tourette syndrome from controls. JNeurol Sci 2009, 276(1):45-48.
73. Hoekstra P.J., Manson W.L., Steenhuis M.P., et al. Association of common cold with exacerbations in pediatric but not adult patients with tic disorder: a prospective longitudinal study. JChild Adolesc Psychopharmacol 2005, 15(2):285-292.
74. Edwards M.J., Dale R.C., Church A.J., et al. Adult-onset tic disorder, motor stereotypies, and behavioural disturbance associated with antibasal ganglia antibodies. Mov Disord 2004, 19(10):1190-1196.
75. Edwards M., Dale R., Church A., et al. Adystonic syndrome associated with anti-basal ganglia antibodies. JNeurol Neurosurg Psychiatry 2004, 75(6):914-916.
76. Yiş U., Kurul S.H., Çakmakçi H., et al. Mycoplasma pneumoniae: nervous system complications in childhood and review of the literature. Eur J Pediatr 2008, 167(9):973-978.
77. Müller N., Riedel M., Blendinger C., et al. Childhood Tourette's syndrome and infection with mycoplasma pneumoniae. Am J Psychiatry 2000, 157:481-482.
78. Müller N., Abele-Horn M., Riedel M. Infection with Mycoplasma pneumoniae and Tourette's syndrome (TS): increased anti-mycoplasmal antibody titers in TS. Psychiatry Res 2004, 129:119-125.
79. Allen A.J., Leonard H.L., Swedo S.E. Case study: a new infection-triggered, autoimmune subtype of pediatric OCD and Tourette's syndrome. JAm Acad Child Adolesc Psychiatry 1995, 34(3):307-311.
80. Fallon B., Nields J., Parsons B., et al. Psychiatric manifestations of Lyme borreliosis. JClin Psychiatry 1993, 54(7):263-268.
81. Fallon B.A., Nields J.A. Lyme disease: a neuropsychiatric illness. Am J Psychiatry 1994, 151(11):1571-1583.
82. Fallon B.A., Kochevar J.M., Gaito A., et al. The underdiagnosis of neuropsychiatric Lyme disease in children and adults. Psychiatr Clin North Am 1998, 21(3):693-703.
83. Tager F.A., Fallon B.A., Keilp J., et al. Acontrolled study of cognitive deficits in children with chronic Lyme disease. JNeuropsychiatry Clin Neurosci 2001, 13(4):500-507.
84. Riedel M., Straube A., Schwarz M.J., et al. Lyme disease presenting as Tourette's syndrome. Lancet 1998, 351(9100):418-419.
85. Snider L.A., Seligman L.D., Ketchen B.R., et al. Tics and problem behaviors in schoolchildren: prevalence, characterization, and associations. Pediatrics 2002, 110(2):331-336.
86. Asnes R.S., Mones R.L. Extraordinary urinary frequency. Pediatrics 1991, 87(6):953.
87. Wang H., Chang H., Chang S. Pollakiuria in children with tic disorders. Chang Gung Med J 2005, 28(11):773.
88. Calkin C.V., Carandang C.G. Certain eating disorders may be a neuropsychiatric manifestation of PANDAS: case report. JCan Acad Child Adolesc Psychiatry 2007, 16(3):132.
89. Sokol M.S., Gray N.S. Case study: an infection-triggered, autoimmune subtype of anorexia nervosa. JAm Acad Child Adolesc Psychiatry 1997, 36(8):1128-1133.
90. Sokol M.S. Infection-triggered anorexia nervosa in children: clinical description of four cases. JChild Adolesc Psychopharmacol 2000, 10(2):133-145.
91. Rubenstein C.S., Pigott T.A., L'Heureux F., et al. Apreliminary investigation of the lifetime prevalence of anorexia and bulimia nervosa in patients with obsessive compulsive disorder. JClin Psychiatry 1992, 53:309-314.
92. Hirani V., Serpell L., Willoughby K., et al. Typology of obsessive-compulsive symptoms in children and adolescents with anorexia nervosa. Eat Weight Disord 2010, 15(1-2):e86-e89.
93. Dale R., Heyman I., Surtees R., et al. Dyskinesias and associated psychiatric disorders following streptococcal infections. Arch Dis Child 2004, 89(7):604-610.
94. Elia J., Dell M.L., Friedman D.F., et al. PANDAS with catatonia: a case report. Therapeutic response to lorazepam and plasmapheresis. JAm Acad Child Adolesc Psychiatry 2005, 44(11):1145-1150.
95. Kerbeshian J., Burd L., Tait A. Chain reaction or time bomb: a neuropsychiatric-developmental/neurodevelopmental formulation of tourettisms, pervasive developmental disorder, and schizophreniform symptomatology associated with PANDAS. World J Biol Psychiatry 2007, 8(3):201-207.
96. Mathew S.J. PANDAS variant and body dysmorphic disorder. Am J Psychiatry 2001, 158(6):963.
97. Kuluva J., Hirsch S., Coffey B. PANDAS and paroxysms: a case of conversion disorder?. JChild Adolesc Psychopharmacol 2008, 18(1):109-115.
98. Kirvan C.A., Swedo S.E., Heuser J.S., et al. Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat Med 2003, 9(7):914-920.
99. Kirvan C.A., Swedo S.E., Snider L.A., et al. Antibody-mediated neuronal cell signaling in behavior and movement disorders. JNeuroimmunol 2006, 179(1):173-179.
100. Church A., Dale R., Giovannoni G. Anti-basal ganglia antibodies: a possible diagnostic utility in idiopathic movement disorders?. Arch Dis Child 2004, 89(7):611-614.
101. Pavone P., Bianchini R., Parano E., et al. Anti-brain antibodies in PANDAS versus uncomplicated streptococcal infection. Pediatr Neurol 2004, 30(2):107-110.
102. Singer H.S., Hong J.J., Yoon D.Y., et al. Serum autoantibodies do not differentiate PANDAS and Tourette syndrome from controls. Neurology 2005, 65(11):1701-1707.
103. Dale R., Church A., Candler P., et al. Serum autoantibodies do not differentiate PANDAS and Tourette syndrome from controls. Neurology 2006, 66(10):1612.
104. Brimberg L., Benhar I., Mascaro-Blanco A., et al. Behavioral, pharmacological, and immunological abnormalities after streptococcal exposure: a novel rat model of Sydenham chorea and related neuropsychiatric disorders. Neuropsychopharmacology 2012, 37:2076-2087.
105. Yaddanapudi K., Hornig M., Serge R., et al. Passive transfer of streptococcus-induced antibodies reproduces behavioral disturbances in a mouse model of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection. Mol Psychiatry 2009, 15(7):712-726.
106. Cox C.J., Sharma M., Leckman J.F., et al. Brain human monoclonal autoantibody from Sydenham chorea targets dopaminergic neurons in transgenic mice and signals dopamine D2 receptor: implications in human disease. JImmunol 2013, 191(11):5524-5541.
107. Schwartz R.H., Wientzen R.L., Pedreira F., et al. Penicillin V for group A streptococcal pharyngotonsillitis: a randomized trial of seven vs ten days' therapy. JAMA 1981, 246(16):1790-1795.
108. Schwartz R.H., Hayden G.F., Wientzen R. Children less than three-years-old with pharyngitis are group A streptococci really that uncommon?. Clin Pediatr 1986, 25(4):185-188.
109. Murphy T.K., Toufexis M.D. PANDAS: Immune Related OCD. Handbook of Assessing Variants and Complications in Anxiety Disorders 2013, 193-199. Springer, New York. D. McKay, E. Storch (Eds.).
110. O'Connor S.P., Darip D., Fraley K., et al. The human antibody response to streptococcal C5a peptidase. JInfect Dis 1991, 163(1):109-116.
111. Johnson D.R., Kurlan R., Leckman J., et al. The human immune response to streptococcal extracellular antigens: clinical, diagnostic, and potential pathogenetic implications. Clin Infect Dis 2010, 50(4):481-490.
112. Kaplan E.L., Rothermel C.D., Johnson D.R. Antistreptolysin O and anti-deoxyribonuclease B titers: normal values for children ages 2 to 12 in the United States. Pediatrics 1998, 101(1):86-88.
113. Shet A., Kaplan E.L. Clinical use and interpretation of group A streptococcal antibody tests: a practical approach for the pediatrician or primary care physician. Pediatr Infect Dis J 2002, 21(5):420-426.
114. Gerber M.A. Comparison of throat cultures and rapid strep tests for diagnosis of streptococcal pharyngitis. Pediatr Infect Dis J 1989, 8(11):820-824.
115. Talkington D.F., Shott S., Fallon M.T., et al. Analysis of eight commercial enzyme immunoassay tests for detection of antibodies to Mycoplasma pneumoniae in human serum. Clin Diagn Lab Immunol 2004, 11(5):862-867.
116. Waites K.B. New concepts of Mycoplasma pneumoniae infections in children. Pediatr Pulmonol 2003, 36(4):267-278.
117. Ozaki T., Nishimura N., Ahn J., et al. Utility of a rapid diagnosis kit for Mycoplasma pneumoniae pneumonia in children, and the antimicrobial susceptibility of the isolates. JInfect Chemother 2007, 13(4):204-207.
118. Clyde W.A. Mycoplasma pneumoniae respiratory disease symposium: summation and significance. Yale J Biol Med 1983, 56(5-6):523.
119. Dalmau J., Lancaster E., Martinez-Hernandez E., et al. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 2011, 10(1):63-74.
120. Gresa-Arribas N., Titulaer M.J., Torrents A., et al. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol 2014, 13:167-177.
121. Suh-Lailam B.B., Haven T.R., Copple S.S., et al. Anti-NMDA-receptor antibody encephalitis: performance evaluation and laboratory experience with the anti-NMDA-receptor IgG assay. Clin Chim Acta 2013, 421:1-6.
122. Ayoub E.M., Wannamaker L.W. Evaluation of the streptococcal desoxyribo-nuclease b and diphosphopyridine nucleotidase antibody tests in acute rheumatic fever and acute glomerulonephritis. Pediatrics 1962, 29(4):527-538.
123. Stollerman G.H., Lewis A.J., Schultz I., et al. Relationship of immune response to group A streptococci to the course of acute, chronic and recurrent rheumatic fever. Am J Med 1956, 20(2):163-169.
124. Ayoub E.M., Wannamaker L.W. Streptococcal antibody titers in Sydenham's chorea. Pediatrics 1966, 38(6):946-956.
125. Holm S.E. Treatment of recurrent tonsillopharyngitis. JAntimicrob Chemother 2000, 45(Suppl 1):31-35.
126. Murphy T.K. Infections and Tic Disorders. Tourette Syndrome 2013, 168-201. Oxford University Press, New York. D. Martino, J.F. Leckman (Eds.).
127. Murphy T., Storch E., Turner A., et al. Maternal history of autoimmune disease in children presenting with tics and/or obsessive-compulsive disorder. JNeuroimmunol 2010, 229(1):243-247.
128. Patterson P.H. Maternal infection: window on neuroimmune interactions in fetal brain development and mental illness. Curr Opin Neurobiol 2002, 12(1):115-118.
129. Vincent A., Deacon R., Dalton P., et al. Maternal antibody-mediated dyslexia? Evidence for a pathogenic serum factor in a mother of two dyslexic children shown by transfer to mice using behavioural studies and magnetic resonance spectroscopy. JNeuroimmunol 2002, 130(1):243-247.
130. Mackay I.R., Rosen F.S., Zinkernagel R.M. Maternal antibodies, childhood infections, and autoimmune diseases. NEngl J Med 2001, 345(18):1331-1335.
131. Lewin A.B., Storch E.A., Murphy T.K. Pediatric autoimmune neuropsychiatric disorders associated with Streptococcus in identical siblings. JChild Adolesc Psychopharmacol 2011, 21(2):177-182.
132. Shulman S.T., Bisno A.L., Clegg H.W., et al. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. Clin Infect Dis 2012, 55(10):e86-e102.
133. Falcini F., Lepri G., Rigante D., et al. PReS-FINAL-2252: descriptive analysis of pediatric autoimmune neuropsychiatric disorder associated with streptococcus infection (PANDAS) in a cohort of 65 Italian patients. Pediatr Rheumatol 2013, 11(Suppl 2):P242.
134. Ruuskanen O. Safety and tolerability of azithromycin in pediatric infectious diseases: 2003 update. Pediatr Infect Dis J 2004, 23(2):S135-S139.
135. Jacobs M.R., Johnson C.E. Macrolide resistance: an increasing concern for treatment failure in children. Pediatr Infect Dis J 2003, 22(8):S131-S138.
136. Strunk R.C., Bacharier L.B., Phillips B.R., et al. Azithromycin or montelukast as inhaled corticosteroid-sparing agents in moderate-to-severe childhood asthma study. JAllergy Clin Immunol 2008, 122(6):1138-1144.e4.
137. Murphy TK, Parker-Athill EC, Lewin AB, etal. Cefdinir for New Onset Pediatric Neuropsychiatric Disorders: A Pilot Randomized Trial. Journal of Child & Adolescent Psychopharmacology, in press.
138. Walker K., Brink A., Lawrenson J., et al. Treatment of Sydenham chorea with intravenous immunoglobulin. J Child Neurol 2012, 27:147-155.
139. Garvey M.A., Snider L.A., Leitman S.F., et al. Treatment of Sydenham's chorea with intravenous immunoglobulin, plasma exchange, or prednisone. J Child Neurol 2005, 20:424-429.
140. Hoekstra P.J., Minderaa R.B., Kallenberg C. Lack of effect of intravenous immunoglobulins on tics: a double-blind placebo-controlled study. JClin Psychiatry 2004, 65(4):537-542.
141. Winters J.L. Plasma exchange: concepts, mechanisms, and an overview of the American Society for Apheresis guidelines. Hematology Am Soc Hematol Educ Program 2012, 2012(1):7-12.
142. Goldstein S.L. Therapeutic apheresis in children: special considerations. Seminars in Dialysis 2012, 25(2):165-170.
143. Sayyah M., Boostani H., Pakseresht S., et al. Apreliminary randomized double-blind clinical trial on the efficacy of celecoxib as an adjunct in the treatment of obsessive-compulsive disorder. Psychiatry Res 2011, 189(3):403-406.
144. Baugh R.F., Archer S.M., Mitchell R.B., et al. Clinical practice guideline tonsillectomy in children. Otolaryngol Head Neck Surg 2011, 144(Suppl 1):S1-S30.
145. Frohna J.G. Effectiveness of adenotonsillectomy in children with mild symptoms of throat infections or adenotonsillar hypertrophy: open, randomised controlled trial. JPediatr 2005, 146(3):435-436.
146. Blakley B.W., Magit A.E. The role of tonsillectomy in reducing recurrent pharyngitis: a systematic review. Otolaryngol Head Neck Surg 2009, 140(3):291-297.
147. Alexander A.A., Patel N.J., Southammakosane C.A., et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS): an indication for tonsillectomy. Int J Pediatr Otorhinolaryngol 2011, 75(6):872-873.
148. Batuecas Caletrío Á., Sánchez González F., Santa Cruz Ruiz S., et al. PANDAS Syndrome: a new tonsillectomy indication?. Acta Otorrinolaringol Esp 2008, 59(7):362-363. [in Spanish].
149. Heubi C., Shott S.R. PANDAS: pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections-an uncommon, but important indication for tonsillectomy. Int J Pediatr Otorhinolaryngol 2003, 67(8):837-840.
150. Orvidas L.J., Slattery M.J. Pediatric autoimmune neuropsychiatric disorders and streptococcal infections: role of otolaryngologist. Laryngoscope 2001, 111(9):1515-1519.
151. Murphy T.K., Lewin A.B., Parker-Athill E.C., et al. Tonsillectomies and adenoidectomies do not prevent the onset of pediatric autoimmune neuropsychiatric disorder associated with group A streptococcus. Pediatr Infect Dis J 2013, 32:834-838.
152. Obregon D., Parker-Athill E.C., Tan J., et al. Psychotropic effects of antimicrobials and immune modulation by psychotropics: implications for neuroimmune disorders. Neuropsychiatry (London) 2012, 2(4):331-343.
153. Tona J. Pediatric autoimmune neuropsychiatric disorders. OT Practice 2011.